Study uncovers why targeted therapy fails in some non-small cell lung cancer patients

FHS
June 13, 2024
1:13 pm

The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been discovered by researchers from UCL, the Francis Crick Institute and AstraZeneca.

Dextromethorphan found to have potential in treating lung fibrosis

A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number

December 23, 2024

J&J to phase out Janssen name in corporate rebrand

Janssen, a brand name that for six decades has been emblazoned on Johnson & Johnson’s pharmaceutical laboratories and prescription drugs, will be phased out as

September 15, 2023

How were antibiotics used during the COVID-19 pandemic?

Researchers explores the application of antimicrobial stewardship in the antibiotic prescribing guidelines during the COVID-19 pandemic.

October 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.